D. E. Shaw & Co., Inc.

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in ORIC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$562,421

+$431,362 QoQ

Shares Held

44,390

+177.1% QoQ

Ownership

0.043%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. ORIC ranks #153 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	5,625,825	$919,934,903
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,059,062	$350,411,843
3	BBIO	BridgeBio Pharma, Inc.	2,545,486	$189,027,789
4	PCVX	Vaxcyte, Inc.	2,865,318	$166,503,628
5	EXEL	Exelixis, Inc.	3,603,063	$154,535,371
6	HALO	Halozyme Therapeutics, Inc.	1,868,708	$120,774,597
7	PTCT	Ptc Therapeutics, Inc.	1,640,381	$111,759,157
8	VRTX	Vertex Pharmaceuticals Inc / Ma	248,960	$111,170,598

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$562,421	44,390	+177.1%	Shares	Defined	2026-05-15
2025-12-31	$131,059	16,022	-83.7%	Shares	Defined	2026-02-17
2023-12-31	$905,583	98,433	-68.0%	Shares	Defined	2024-02-14
2023-09-30	$1,860,247	307,479	-32.2%	Shares	Defined	2023-11-14
2023-06-30	$3,517,212	453,249	-21.6%	Shares	Defined	2023-08-14
2023-03-31	$3,296,327	578,303	-4.1%	Shares	Defined	2023-05-15
2022-12-31	$3,550,415	602,787	+12.9%	Shares	Defined	2023-02-14
2022-09-30	$1,708,441	533,888	+5.5%	Shares	Defined	2022-11-14
2022-06-30	$2,266,821	505,987	+106.6%	Shares	Defined	2022-08-15
2022-03-31	$1,307,760	244,899	+2395.9%	Shares	Defined	2022-05-16
2021-03-31	$240,394	9,812	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.